2m 2m 2m 2m 2m 2m 2m
PULMONX (LUNG)
NASDAQ
$2.11-$0.01 (-0.52%)
Price as of Aug 03, 2026 7:57 PM EDT- $68.8MMarket Cap
- 28.48%1-Year Change
- Medical DevicesIndustry
PULMONX (LUNG)
$2.11-$0.01 (-0.52%)
LUNG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.12 | ||
Change | +$0.49 (+30.06%) | ||
Open | $1.67 | ||
High | $2.15 | ||
Low | $1.65 | ||
Previous Close | $1.63 | ||
Volume | 2,213,553 | ||
30-Day Average Volume | 604,342 | ||
1-Week Change | 73.77% | ||
1-Month Change | 52.52% | ||
1-Year Change | 28.48% | ||
3-Year Change | -84.00% | ||
5-Year Change | -94.59% | ||
Fundamentals | |||
Shares Outstanding | 42.2M | ||
Total Assets | $120.0M | ||
Market Cap | $68.8M | ||
Enterprise Value | $44.6M | ||
Period: QTR TTM FY | |||
Revenue | $20.6M | ||
Net Income | -$13.7M | ||
Free Cash Flow | -$10.1M | ||
EBIT | -$13.3M | ||
EBITDA | -$13.1M | ||
Net Working Capital | $73.8M | ||
EPS | -$0.33 | ||
Enterprise Value/EBITDA | -3 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 2 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue